Complete Up To Date Information about Doxirobe™ Gel.
NADA Number: 141-082 | |
| Proprietary Name |
Doxirobe™ Gel HESKA™ Perioceutic™ Gel HESKA™ Periodontal Disease Therapeutic |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Doxycycline Hyclate |
| Species |
Dog, restricted during pregnancy Dog, excluding under 12 months |
| Routes of Administration |
Subgingivally to the peridontal pocket of teeth |
| Dose Form |
Liquid |
| Drug Form |
Liquid |
| Dispensing Status |
RX |
| Patent Number |
4938763 5077049 5278201 5324519 |
| Exclusivity |
No active ingredient of the drug has been previously approved. |
|
Dosage Amount, Indications & Limitations |
522.778 Doxycycline hyclate. Specifications: Doxycycline hyclate solution contains 8.5 percent doxycycline activity. A syringe of N-methyl-2-pyrrolidone and poly (DL-lactide) mixed with a syringe of doxycycline produces 0.5 milliliter of solution. Conditions of use: Dogs (over 1 year) Amount: Apply subgingivally to periodontal pocket(s) of affected teeth. Indications: For treatment and control of periodontal disease. Limitations: Do not use in dogs less than 1-year old. Use of tetracyclines during tooth development has been associated with permanent discoloration of teeth. Do not use in pregnant bitches. Use in breeding dogs has not been evaluated. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |